Desk›Healthcare› Wockhardt Ltd
Wockhardt Ltd
BSE 532300 · NSE WOCKPHARMA · ISIN INE049B01025 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,960.90
+4.29%
BSE close, 28 August 2026
₹31,861.80 cr
16.2 cr shares · Mid cap
₹16,131.21 cr
as published
89.5× · 18.05×
EPS ₹21.91 · BV ₹108.64
1,739.00 / 317.00
₹ cr, as filed
14
4 selected · 29%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -19.0% |
|---|---|
| Against 52-week low | +80.4% |
| Day change | +4.29% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹21.91 |
|---|---|
| Price / earnings | 89.50× |
| Price / book | 18.05× |
| Book value — derived, price ÷ P/B | ₹108.64 |
| Return on equity | 20.17% |
| Operating margin | 34.05% |
| Net margin | 19.07% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 20.17%
- ROE as published
- 20.17%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 561.00 | 107.00 | 6.62 | 34.05% | 19.07% |
| Mar-26 · Q | 516.00 | 167.00 | 10.29 | 48.64% | 32.36% |
| FY25-26 | 1,739.00 | 317.00 | 19.54 | 39.05% | 18.23% |
Quarter on quarter
- Revenue, quarter on quarter
- +8.7%
- Net profit, quarter on quarter
- -35.9%
- Operating margin, quarter on quarter
- -1,459 bps
Disclosure profile 14 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 3 |
| Newspaper Publication | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Monitoring Agency | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 10 |
| Total | 14 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
14 filings · 4 selected · busiest 2026-08-10
Filing rhythm · the twelve most recent
2026-08-072026-10-09
SelectedProcedural
Filings
14 in the window · 9 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find attached the Certificate received from MUFG Intime India Private Limited, Registrar and ....
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Closure of Trading Window
The Trading Window for dealing in the equity shares of the Company will be closed from 1st October, 2026 until 48 hours after the declaration of Unaudited financial results for quarter ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 August 2026 ·
Disclosure under Regulation 30A of LODR
Pursuant to Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations 2015, we wish to inform you that the Company is in receipt of an Adjudication Order passed by Commissioner ....
Others View filing →
-
25 August 2026 ·
Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations, 2015, we enclose herewith a copy of newspaper advertisement published today i.e. 25th August, ....
Company Update / Newspaper Publication View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find enclosed herewith Scrutinizer's Report on the combined voting results of remote e-voting and e-voting during the 27th AGM of the Company
AGM/EGM / AGM View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, the Proceedings of the 27th AGM of the Company
AGM/EGM / AGM View filing →
-
10 August 2026 ·
Monitoring Agency Report
Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICDR) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilisation ....
Company Update / Monitoring Agency Report View filing →
-
10 August 2026 ·
Press Release / Media Release
Please find enclosed Press Release - "Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance".
Company Update / Press Release / Media Release View filing →
-
10 August 2026 ·
Press Release / Media Release
Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026
Company Update / Press Release / Media Release View filing →
-
10 August 2026 ·
Financial Results For The Quarter Ended 30Th June, 2026
Pursuant to Regulation 30 of SEBI Listing Regulations, the Board of Directors at its meeting held today i.e. 10th August, 2026, has approved the Unaudited Financial Results (Standalone ....
Result / Financial Results View filing →
-
10 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulation 30 of SEBI Listing Regulations, Board of Directors at its meeting held today i.e 10th August, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) ....
Board Meeting / Outcome of Board Meeting View filing →
-
7 August 2026 ·
Newspaper Publication
Pursuant to Regulation 30 read with schedule III (Part A Para A) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find ....
Company Update / Newspaper Publication View filing →
-
5 August 2026 ·
Addendum To The Notice Of 27Th Annual General Meeting Of The Company
Please find enclosed herewith the addendum to the Notice of the 27th Annual General Meeting of the Company scheduled to be held on Monday, 10th August, 2026.
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Board Meeting Intimation for Approval Of The Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June, 2026.
Wockhardt Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI ....
Board Meeting / Board Meeting View filing →
RSS feed for Wockhardt Ltd · the 50 most recent filings